| Scope | Feature |
|---|---|
| Version | v3.18.0 |
| Release date | September 28, 2026 |
| Deployed to Confimedis Cloud | September 29, 2026 |
| Affected modules | Reports, Users, General, eConsent, Subjects, Participant, Forms, Documents |
Validation by Confimedis
Confimedis GmbH has validated this release in accordance with its quality management system and GAMP 5 before deployment, re-executing the test cases of the Operational Qualification (OQ) for the affected functions according to their risk classification. A release does not change the configuration of your study, such as forms, edit checks, roles, or users, which your Performance Qualification (PQ) covers. Where existing settings are migrated, the note says so. The Validation Package of every release, including the OQ report and a prefilled Validation Summary Report (VSR), is available on request and only needed for an initial validation or a revalidation. A test project is a copy of your study without patient data, created via CDISC ODM export and import.
Recommended action on your side
Review before useNote from Confimedis on version 3.18.0
Three changes are visible in running studies: In the participant app, a visit now counts as answered only once the participant has completed one of its forms, so its notifications continue while only the study team has entered data. The study team can now withdraw a consent that the participant signed in a survey or the participant app. The recruitment card of the dashboard now opens the new default report Recruitment statistics. Existing forms, roles, and sites are unchanged, and no PQ test item is affected. If you set the signer of the consent interview signature to Study team only, execute PQ 7.2 Consent process can be completed in a test project first.
Summary: Reports gain line, scatter, and bubble charts, the subject status and the next event as fields, a CSV download of every chart, and the new default report Recruitment statistics. In eConsent, the signature of the person conducting the consent interview can be reserved for the study team, and the study team can withdraw a consent signed by the participant.